According to The Insight Partners, The Central Nervous System Biomarkers Market size is expected to reach US$ 13.53 Billion by 2034 from US$ 6.62 Billion in 2025. The market is estimated to record a CAGR of 8.27% from 2026 to 2034. The Central Nervous System (CNS) Biomarkers Market is experiencing steady growth, driven by the increasing prevalence of neurological disorders and the growing...